Is TCRR or DGRO a better dividend investment in 2026?

TCRR currently yields 135.14% with a 5% 5-year dividend growth rate. DGRO yields 2.10% with 9.5% growth. The better choice depends on your goal: TCRR offers higher current income.

What is the dividend yield difference between TCRR and DGRO?

TCRR has a forward dividend yield of 135.14% ($2.00/share annually). DGRO yields 2.10% ($1.47/share annually). The yield gap is 133.04 percentage points.

Home › Compare › TCRR vs DGRO

TCRR vs DGRO: Dividend Comparison 2026

TCRR yields 135.14% · DGRO yields 2.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TCRR wins by $14.86M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TCRR

● Live price

135.14%

Share price

$1.48

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$14.90M

Annual income

$6,066,079.91

Full TCRR calculator →

DGRO

iShares Core Dividend Growth ETF

● Live price

2.10%

Share price

$70.18

Annual div

$1.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.6K

Annual income

$235.38

Full DGRO calculator →

Portfolio growth — TCRR vs DGRO

📍 TCRR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TCRR	DGRO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TCRR + DGRO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TCRR pays

DGRO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TCRR

Annual income on $10K today (after 15% tax)

$11,486.49/yr

After 10yr DRIP, annual income (after tax)

$5,156,167.92/yr

DGRO

Annual income on $10K today (after 15% tax)

$178.14/yr

After 10yr DRIP, annual income (after tax)

$200.07/yr

At 15% tax rate, TCRR beats the other by $5,155,967.85/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TCRR + DGRO for your $10,000?

TCRR: 50%DGRO: 50%

100% DGRO50/50100% TCRR

Portfolio after 10yr

$7.46M

Annual income

$3,033,157.65/yr

Blended yield

40.64%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on TCRR right now

TCRR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$5.00

+237.8% upside vs current

Range: $5.00 — $5.00

Altman Z

-7.2

Piotroski

2/9

DGRO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TCRR buys

DGRO buys

No recent congressional trades found for TCRR or DGRO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTCRRDGRO

Forward yield	135.14% ✓	2.10%
Annual dividend / share	$2.00 ✓	$1.47
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$14.90M	$31.6K ✓
Annual income after 10y	$6,066,079.91 ✓	$235.38
Total dividends collected	$13.68M ✓	$2.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: TCRR vs DGRO ($10,000, DRIP)

Year	TCRR Portfolio	TCRR Income/yr	DGRO Portfolio	DGRO Income/yr	Gap
1← crossover	$24,214	$13,513.51	$11,290	$209.57	+$12.9K → TCRR
2	$56,489	$30,580.34	$12,722	$213.54	+$43.8K → TCRR
3	$127,118	$66,675.01	$14,314	$217.18	+$112.8K → TCRR
4	$276,241	$140,224.56	$16,080	$220.53	+$260.2K → TCRR
5	$580,365	$284,787.59	$18,040	$223.59	+$562.3K → TCRR
6	$1,180,170	$559,178.96	$20,215	$226.40	+$1.16M → TCRR
7	$2,325,480	$1,062,698.63	$22,627	$228.96	+$2.30M → TCRR
8	$4,445,281	$1,957,016.59	$25,302	$231.31	+$4.42M → TCRR
9	$8,252,658	$3,496,207.78	$28,268	$233.44	+$8.22M → TCRR
10	$14,896,424	$6,066,079.91	$31,557	$235.38	+$14.86M → TCRR

TCRR vs DGRO: Complete Analysis 2026

TCRR — Stock

TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. It is also developing TC-510, a mesothelin-targeted TRuC-T cell that has completed preclinical trials to treat solid tumors; and TC-520, a fratricide resistant CD70 targeting TRuC-T cell for the treatment of renal cell carcinoma. The company was formerly known as TCR2, Inc. and changed its name to TCR2 Therapeutics Inc. in November 2016. TCR2 Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Full TCRR Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →

📬

Get this TCRR vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TCRR vs SCHD TCRR vs JEPI TCRR vs O TCRR vs KO TCRR vs MAIN TCRR vs VIG TCRR vs NOBL TCRR vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.